期刊文献+

诱导型一氧化氮合酶在GK糖尿病大鼠心肌梗死后的表达 被引量:1

Expression of inducible nitric oxide synthase in diabetic rats with myocardial infarction
下载PDF
导出
摘要 目的本研究通过制作GK糖尿病大鼠及非糖尿病大鼠心肌梗死模型,观察诱导型一氧化氮合酶(iNOS)的表达在糖尿病大鼠合并心肌梗死时与非糖尿病大鼠心肌梗死时的变化,为冠心病合并糖尿病的心脏病理改变提供理论基础与科学依据。方法应用体质量在200~250g的雄性GK糖尿病大鼠及其对照雄性Wistar大鼠通过开胸手术结扎麻醉大鼠冠状动脉左前降支制作大鼠在体心肌梗死模型。心肌梗死模型制作前测量血糖。手术成功后分组饲养大鼠3周。3周后,测量血糖,活体剪取心脏,进行iNOS的免疫组织化学染色及实时聚合酶链反应(RT-PCR)检测。结果①GK糖尿病大鼠血糖明显高于Wistar大鼠血糖(P<0.05);②Wistar心肌梗死组与GK心肌梗死组在缺血区可见到心肌细胞iNOS大量阳性染色,但GK心肌梗死组与Wistar心肌梗死组相比,iNOS阳性染色减少,二者吸光度测定值差异有统计学意义(P<0.05);③Wistar心肌梗死组与GK心肌梗死组iNOSmRNA表达在缺血区明显增加,但GK心肌梗死组iNOSmRNA表达减少,二者之间差异有统计学意义(P<0.05)。结论iNOS在糖尿病大鼠合并心肌梗死时其在缺血区的表达是降低的,表明高血糖可能抑制iNOS的表达,使体内一氧化氮(NO)生成减少,不利于梗死后血供的恢复。 Objective To investigate the expression of inducible nitric oxide synthase (iNOS) in GK diabetic rats with myocardial infarction by using myocardial infarction models of diabetic rats and non-diabetic rats. Methods Experiments were carried out in male GK diabetes rats and male Wistar rats (both weighed 200-250g). Left anterior descending coronary artery (LADCA) was ligated with silk ligature in anesthetized rats. Rats were divided into four groups and raised for 3 weeks. Before operation, blood glucose of each rat was measured. 3 weeks after operation, blood glucose of each rat was also measured before hearts of all survived rats were excised, then the expression of iNOS was detected in all groups. Results ①Blood glucose of GK rats was significantly higher than that of Wistar rats (P〈0.05), ② Positive staining of iNOS increased in isehemie zone of Wistar operated group and GK operated group, but the expression of iNOS in GK operated group decreased compared with Wistar operated group (P〈0.05) ③The expression of iNOS mRNA increased in ischemic zone of Wistar operated group and GK operated group, but The expression of iNOS mRNA in GK operated group decreased compared with Wistar operated group (P〈0.05). Conelusion The expression of iNOS in GK diabetic rats with myocardial infarction decreased compared with Wistar rats with myocardial infarct, which indieated that high glucose may decrease the expression of iNOS and the production of nitric oxide in ischemie zone, and do harm to the restore of blood supply after myocardial infarction.
出处 《山西医药杂志(上半月)》 CAS 2009年第5期393-395,共3页 Shanxi Medical Journal
基金 国家自然科学基金(30500212)
关键词 一氧化氮合酶 糖尿病 大鼠 心肌梗死 Nitricoxide synthase Diabeties,mellitus Rats Myocardial infarction
  • 相关文献

参考文献10

  • 1Moncada S,Palmer RM,Higgs EA.Nitric oxide:physiology,pathophysiology,and pharmacology.Pharmacol Rev,1991,43(2):109-142.
  • 2Moncada S,Higgs EA.Molecular mechanisms and therapeutic strategies related to nitric oxide.FASEB J,1995,9(13):1319-1330.
  • 3李星海,孙宗全.HIF-1对大鼠心肌iNOS、VEGF蛋白表达的影响[J].浙江医学,2007,29(8):809-811. 被引量:7
  • 4Brady AJ,Poole-Wilson PA,Harding SE,et al.Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia.Am J Physiol,1992,263(6 Pt 2):1963-1966.
  • 5Gonzalez MA,Selwyn AP.Endothelial function,inflammation,and prognosis in cardiovascular disease.Am J Med,2003,115 Suppl 8A:99-106.
  • 6陆东风,覃军.诱生型一氧化氮合酶基因在心肌梗死大鼠中的表达[J].广州医学院学报,2003,31(3):54-56. 被引量:10
  • 7Nishikawa T,Edelstein D,Du XL,et al.Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.Nature,2000,404(6779):787-790.
  • 8Ceriello A.New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy.Diabetes Care,2003,26(5):1589-1596.
  • 9Brownlee M.Biochemistry and molecular cell biology of diabetic complications.Nature,2001,414(6865):813-820,.
  • 10Giaccia A,Siim BG,Johnson RS.HIF-1 as a target for drug development.Nat Rev Drug Discov,2003,2(10):803-811.

二级参考文献21

  • 1[1]Moncada S,Palmer RM,Higgs EA. Nitric oxide:physiology,pathophysiology,and pharmacology[J]. Pharmacol Rev,1991,43:109-142.
  • 2[2]Ikeda U,Maeda Y,Kawahara Y,et al. Molecular mechanisms and therapeutic strategies related to nitric oxide[J]. FASEB J,1995,9:1319-1330.
  • 3[3]Vallance P,Collier J,Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man[J]. Lancet,1989,2.
  • 4[4]Brady AJ,Poole-Wilson PA,Harding SE,et al. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia[J]. Am J Physiol,1992,263:H1963-H1966.
  • 5[5]Gardiner SM,Kemp PA,March JE,et al. Cardiac and regional haemodynamics,inducible nitric oxide synthase (NOS) activity,and the effects of NOS inhibitors in conscious,endotoxaemic rats[J]. Br J Pharmacol,1995,116:2005-2016.
  • 6[6]Brady AJB,Poole-Wilson PA,Harding SE,et al. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia[J]. Am J Physiol,1992,263:H1963-H1966.
  • 7[7]McKenna TM,Li S,Tao S. PKC mediates LPS- and phorbol-induced cardiac cell nitric oxide synthase activity and hypocontractility[J]. Am J Physiol,1995,269:1891-1898.
  • 8[8]Qingping Feng,Xiangru Lu,Douglas L. Jones,et al. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice.
  • 9[9]Hibbs JB Jr,Taintor RR,Vavrin Z,et al. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine:a molecular mechanism regulating cellular proliferation that targets intracellular iron. In:Moncada S,Higgs EA,eds. Nitric Oxide From L-Arginine:A Bioregulatory System. Amsterdam,Netherlands:Excerpta Medica.
  • 10Wang G L, Jiang B H, Rue E A, et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension[J]. Proc Natl Acad Sci U S A, 1995, 2(12):4.

共引文献15

同被引文献17

  • 1Frangogiannis NG. The immune system and cardiac repair[J].{H}PHARMACOLOGICAL RESEARCH,2008.88-111.
  • 2Lambert JM,Lopez EF,Lindsey ML. Macrophage roles following myocardial infarction[J].{H}International Journal of Cardiology,2008.147-158.
  • 3Gao E,Lei YH,Shang X. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse[J].{H}CIRCULATION RESEARCH,2010.1445-1453.
  • 4Sato S,Hughes RC. Regulation of secretion and surface expres-sion of Mac-2,a galactoside-protein of macrophages[J].{H}Journal of Biological Chemistry,1994.4424-4430.
  • 5Mantovani A,Garlanda C,Locati M. Macrophage diversity and polarization in atherosclerosis:a question of balance[J].Arte-rioscler Thromb Vasc Biol,2009.1419-1423.
  • 6Van den Borne SW,Diez J,Blankesteijn WM. Myocardial remodeling after infarction:the role of myofibroblasts[J].Nat Rev Cardiol,2010.30-37.
  • 7Dobaczewski M,Gonzalez-Quesada C,Frangoqiannis NG. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction[J].{H}Journal of Molecular and Cellular Cardiology,2010,(03):504-511.
  • 8Mannisi JA,Weisman HF,Bush DE. Steroid administration after myocardial infarction promotes early infarct expansion:a study in the rat[J].{H}Journal of Clinical Investigation,1987.1431-1439.
  • 9Okazaki T,Ebihara S,Asada M. Macrophage colony-stimu-lating factor improves cardiac function after ischemic injury by inducing vascular endothelial growth factor production and sur-vival of cardiomyocytes[J].{H}AMERICAN JOURNAL OF PATHOLOGY,2007.1093-1103.
  • 10Leor J,Rozen L,Zuloff-Shani A. Ex vivo activated human macrophages improve healing,remodeling,and function of the infarcted heart[J].{H}CIRCULATION,2006.94-100.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部